• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1995 - 1997年土耳其伊兹密尔的癌症生存率

Cancer survival in Izmir, Turkey, 1995-1997.

作者信息

Eser S

机构信息

Izmir Cancer Registry, Izmir Provincial Health Directorate, Izmir, Turkey.

出版信息

IARC Sci Publ. 2011(162):237-42.

PMID:21675428
Abstract

The Izmir cancer registry, the first population-based cancer registry in Turkey, was established in 1992. Cancer registration is now done by active methods. The registry contributed data on survival for 12 cancer sites or types registered in 1995-1997. Follow-up was predominantly done by active methods with median follow-up ranging between 17-72 months for different cancers. The proportion with histologically verified diagnosis for various cancers ranged between 84-100%; there were no death certificate only (DCO) cases; 98-100% of total registered cases were included for the survival analysis. Complete follow-up at five years ranged from 79-98% for different cancers. Five-year age-standardized relative survival rates of common cancers were breast (77%), urinary bladder (70%), Larynx (69%), colon (53%), rectum (52%), non-Hodgkin Lymphoma (50%) and cervix (58%). Five-year relative survival by age group portrayed decreasing survival with increasing age at diagnosis for cancer of the cervix, and was fluctuating for other cancers. Decreasing survival with increasing clinical extent of disease was also noted.

摘要

伊兹密尔癌症登记处是土耳其首个基于人群的癌症登记处,于1992年成立。目前通过主动方法进行癌症登记。该登记处提供了1995 - 1997年登记的12个癌症部位或类型的生存数据。随访主要通过主动方法进行,不同癌症的中位随访时间在17 - 72个月之间。各种癌症经组织学证实诊断的比例在84% - 100%之间;没有仅依据死亡证明(DCO)的病例;纳入生存分析的登记病例总数占98% - 100%。不同癌症的五年完全随访率在79% - 98%之间。常见癌症的五年年龄标准化相对生存率分别为:乳腺癌(77%)、膀胱癌(70%)、喉癌(69%)、结肠癌(53%)、直肠癌(52%)、非霍奇金淋巴瘤(50%)和子宫颈癌(58%)。按年龄组划分的五年相对生存率显示,子宫颈癌诊断时年龄越大生存率越低,其他癌症则有波动。还注意到随着疾病临床分期增加生存率降低。

相似文献

1
Cancer survival in Izmir, Turkey, 1995-1997.1995 - 1997年土耳其伊兹密尔的癌症生存率
IARC Sci Publ. 2011(162):237-42.
2
Cancer survival in Mumbai (Bombay), India, 1992-1999.1992 - 1999年印度孟买(旧称: Bombay)的癌症生存率。
IARC Sci Publ. 2011(162):133-42.
3
Cancer survival in Cuba, 1994-1995.1994 - 1995年古巴的癌症生存率
IARC Sci Publ. 2011(162):89-95.
4
Cancer survival in Kampala, Uganda, 1993-1997.1993 - 1997年乌干达坎帕拉的癌症生存率
IARC Sci Publ. 2011(162):243-7.
5
Cancer survival in Chiang Mai, Thailand, 1993-1997.泰国清迈1993 - 1997年癌症生存率。
IARC Sci Publ. 2011(162):199-209.
6
Cancer survival in Khon Kaen, Thailand, 1993-1997.1993 - 1997年泰国孔敬府的癌症生存率
IARC Sci Publ. 2011(162):211-6.
7
Cancer survival in Incheon, Republic of Korea, 1997-2001.1997 - 2001年韩国仁川的癌症生存率
IARC Sci Publ. 2011(162):163-9.
8
Cancer survival in Manila, Philippines, 1994-1995.1994 - 1995年菲律宾马尼拉的癌症生存率
IARC Sci Publ. 2011(162):147-50.
9
Cancer survival in Seoul, Republic of Korea, 1993-1997.1993 - 1997年韩国首尔的癌症生存率
IARC Sci Publ. 2011(162):171-8.
10
Cancer survival in Songkhla, Thailand, 1990-1999.泰国宋卡1990 - 1999年的癌症生存率。
IARC Sci Publ. 2011(162):227-35.

引用本文的文献

1
Epidemiological Overview of Hodgkin Lymphoma across the Mediterranean Basin.地中海盆地霍奇金淋巴瘤的流行病学概述。
Mediterr J Hematol Infect Dis. 2014 Jul 1;6(1):e2014048. doi: 10.4084/MJHID.2014.048. eCollection 2014.